Eli Lilly Announces $1 Billion Limerick Expansion, $800 Million Kinsale Facility
Slice of Manufacturing Team
09/16/2024
Key Highlights:
- $1 billion expansion of Limerick site to increase Alzheimer's drug production.
- $800 million expansion of Kinsale facility for diabetes and obesity treatments.
- Limerick will create 150 new jobs, with production set to begin in 2026.
- Advanced technologies like AI and robotics to ensure efficient operations.
- Sustainability initiatives include solar power and reduced energy use.
Source: PR Newswire
Quotes
“ “These investments will boost the production of some of our medicines, helping millions of people with diabetes, obesity and Alzheimer's disease live the healthiest lives possible.” ”
Edgardo Hernandez, EVP and President at Lilly Manufacturing Operations
Our Take:
Eli Lilly's recent $1 billion investment in its Limerick site underscores the company's commitment to addressing some of the world's most pressing health challenges, particularly in Alzheimer's disease. This expansion, paired with their $800 million Kinsale facility, reinforces Lilly's strategic focus on biologics and cutting-edge treatments. Leveraging advanced technologies like AI and robotics, along with strong sustainability initiatives, positions Lilly as a forward-thinking leader in pharmaceutical manufacturing. These investments will not only advance healthcare innovation but also create high-skilled jobs in Ireland, marking a significant economic boost for the region.
